Severe asthma gets first biologic in decades
Author:
- 1 January 2016
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 34 (1) , 10-11
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Anti-IL-5 biologics carve out severe-asthma nicheNature Biotechnology, 2014
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic AsthmaNew England Journal of Medicine, 2014
- Mepolizumab Treatment in Patients with Severe Eosinophilic AsthmaNew England Journal of Medicine, 2014
- Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophiliaJournal of Allergy and Clinical Immunology, 2013
- Determining asthma treatment by monitoring sputum cell counts: effect on exacerbationsEuropean Respiratory Journal, 2006
- Asthma exacerbations and sputum eosinophil counts: a randomised controlled trialThe Lancet, 2002